v3.8.0.1
CONDENSED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Operating expenses:        
Research and development $ 1,124,506 $ 560,514 $ 3,802,149 $ 2,139,671
General and administrative 786,948 991,852 4,020,625 7,257,852
Depreciation 2,834 2,570 8,900 7,811
Total operating expenses 1,914,288 1,554,936 7,831,674 9,405,334
Loss from operations (1,914,288) (1,554,936) (7,831,674) (9,405,334)
Other income (expense):        
Gain (loss) on change in fair value of derivatives 113,724 17,771 (320,131) (807,087)
Interest income 15 0 69 1
Loss before income taxes (1,800,549) (1,537,165) (8,151,736) (10,212,420)
Income taxes (benefit) 0 0 0 0
Net loss (1,800,549) (1,537,165) (8,151,736) (10,212,420)
Preferred stock dividend (22,307) (24,726) (68,915) (85,467)
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (1,822,856) $ (1,561,891) $ (8,220,651) $ (10,297,887)
Net loss per common share, basic and diluted (in Dollars per share) $ (0.07) $ (0.08) $ (0.33) $ (0.55)
Weighted average number of common shares outstanding, basic and diluted (in Shares) 26,071,408 20,581,041 24,762,649 18,847,515

Source